Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
LaggingPerrigo is a leading pure-play self-care company with more than a century of providing high-quality health and wellness solutions to meet the evolving needs of consumers. As one of the originators of the over-the-counter ("OTC") self-care market, Perrigo is led by its vision "To Provide The Best Self-Care For Everyone" and its purpose to "Make Lives Better Through Trusted Health and Wellness Solutions, Accessible To All".
In the company’s own words · 10-K filed Feb 26, 2026 · SEC EDGAR
Business segments
Q2 2026 · $803.1MThe company’s own SEC segment disclosure.
- Upper Respiratory$178.4M22%
- Skin Health$161.8M20%
- Healthy Lifestyle$157.8M20%
- Pain And Sleep$124.6M16%
- Digestive Health$115.7M14%
- Womens Health$64.8M8%
Perrigo Company plc (PRGO) reported revenue of $969M in Q1 2026 (quarter ended March 28, 2026), down 7.2% from the same quarter a year earlier. That came with a gross margin of 34% and net loss of $399M. For the full year FY2025, revenue was $4.25B (−2.8% year on year) and net income −$1.43B. Its largest product in 2026-Q2 was Upper Respiratory at $178M, 22% of the disclosed total, just ahead of Skin Health at 20%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Drug Manufacturers - Specialty & Generic
Ranks #28 of 28 by Smart Score